JD Health Keeps Issued Shares at 3.21 Billion in March; Only 0.02 Million Options Exercised Without New Share Issuance

Bulletin Express04-08

JD Health International Inc. filed its Monthly Return with the Hong Kong Stock Exchange for the period ended 31 March 2026, confirming stable capital structure and minimal equity movements during the month.

The company’s authorised share capital remained unchanged at 100.00 billion ordinary shares with a par value of USD 0.0000005, representing total authorised capital of USD 50,000.

Issued share capital was steady at 3.21 billion ordinary shares, and the group held no treasury shares. JD Health affirmed compliance with the Main Board’s 25% minimum public-float requirement.

Equity incentive activity was limited: • Pre-IPO ESOP: 0.02 million options were exercised, reducing outstanding options to 11.16 million. Exercises were satisfied by shares already held in trust, so no new shares were issued and only USD 0.01 was received. • Post-IPO Share Option Scheme: No grants or exercises; 312.71 million shares remain available for future issuance. • Post-IPO Share Award Scheme: Capacity stands at 15.00 million shares, with no shares granted or vested in March.

There were no warrants, convertible securities, share repurchases, or other equity changes reported for the month.

The filing was signed by Director Dong Cao on 8 April 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137419889?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-08 22:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137419889","market":"hk","top_or_hot":-1,"title":"JD Health Keeps Issued Shares at 3.21 Billion in March; Only 0.02 Million Options Exercised Without New Share Issuance","media":"Bulletin Express","content":"<p>JD Health International Inc. filed its Monthly Return with the Hong Kong Stock Exchange for the period ended 31 March 2026, confirming stable capital structure and minimal equity movements during the month.</p>\n<p>The company’s authorised share capital remained unchanged at 100.00 billion ordinary shares with a par value of USD 0.0000005, representing total authorised capital of USD 50,000.</p>\n<p>Issued share capital was steady at 3.21 billion ordinary shares, and the group held no treasury shares. JD Health affirmed compliance with the Main Board’s 25% minimum public-float requirement.</p>\n<p>Equity incentive activity was limited:\n• Pre-IPO ESOP: 0.02 million options were exercised, reducing outstanding options to 11.16 million. Exercises were satisfied by shares already held in trust, so no new shares were issued and only USD 0.01 was received.\n• Post-IPO Share Option Scheme: No grants or exercises; 312.71 million shares remain available for future issuance.\n• Post-IPO Share Award Scheme: Capacity stands at 15.00 million shares, with no shares granted or vested in March.</p>\n<p>There were no warrants, convertible securities, share repurchases, or other equity changes reported for the month.</p>\n<p>The filing was signed by Director Dong Cao on 8 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD Health Keeps Issued Shares at 3.21 Billion in March; Only 0.02 Million Options Exercised Without New Share Issuance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD Health Keeps Issued Shares at 3.21 Billion in March; Only 0.02 Million Options Exercised Without New Share Issuance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-08 22:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD Health International Inc. filed its Monthly Return with the Hong Kong Stock Exchange for the period ended 31 March 2026, confirming stable capital structure and minimal equity movements during the month.</p>\n<p>The company’s authorised share capital remained unchanged at 100.00 billion ordinary shares with a par value of USD 0.0000005, representing total authorised capital of USD 50,000.</p>\n<p>Issued share capital was steady at 3.21 billion ordinary shares, and the group held no treasury shares. JD Health affirmed compliance with the Main Board’s 25% minimum public-float requirement.</p>\n<p>Equity incentive activity was limited:\n• Pre-IPO ESOP: 0.02 million options were exercised, reducing outstanding options to 11.16 million. Exercises were satisfied by shares already held in trust, so no new shares were issued and only USD 0.01 was received.\n• Post-IPO Share Option Scheme: No grants or exercises; 312.71 million shares remain available for future issuance.\n• Post-IPO Share Award Scheme: Capacity stands at 15.00 million shares, with no shares granted or vested in March.</p>\n<p>There were no warrants, convertible securities, share repurchases, or other equity changes reported for the month.</p>\n<p>The filing was signed by Director Dong Cao on 8 April 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1137419889","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137419889","pubTimestamp":1775658125,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"JD Health International Inc. filed its Monthly Return with the Hong Kong Stock Exchange for the period ended 31 March 2026, confirming stable capital structure and minimal equity movements during the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"京东健康3月份已发行股份维持在32.1亿股；仅行使0.02万份期权，无需发行新股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD Health International Inc. filed its Monthly Return with the Hong Kong Stock Exchange for the period ended 31 March 2026, confirming stable capital structure and minimal equity movements during the month.\nThe company’s authorised share capital remained unchanged at 100.00 billion ordinary shares with a par value of USD 0.0000005, representing total authorised capital of USD 50,000.\nIssued share capital was steady at 3.21 billion ordinary shares, and the group held no treasury shares. JD Health affirmed compliance with the Main Board’s 25% minimum public-float requirement.\nEquity incentive activity was limited:\n• Pre-IPO ESOP: 0.02 million options were exercised, reducing outstanding options to 11.16 million. Exercises were satisfied by shares already held in trust, so no new shares were issued and only USD 0.01 was received.\n• Post-IPO Share Option Scheme: No grants or exercises; 312.71 million shares remain available for future issuance.\n• Post-IPO Share Award Scheme: Capacity stands at 15.00 million shares, with no shares granted or vested in March.\nThere were no warrants, convertible securities, share repurchases, or other equity changes reported for the month.\nThe filing was signed by Director Dong Cao on 8 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137419889","isCrawlerRequest":true}